title: Combination regimens and dose intensification in non-small cell lung cancer: a panel discussion (Part 1).
authors.affiliation: Duke University Medical Center, Durham, NC, USA.
authors.forename: J
authors.initials: J
authors.lastname: Crawford
authors.forename: A Y
authors.initials: AY
authors.lastname: Chang
authors.forename: R J
authors.initials: RJ
authors.lastname: Gralla
authors.forename: P J
authors.initials: PJ
authors.lastname: Souquet
authors.forename: E E
authors.initials: EE
authors.lastname: Vokes
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077235:Vinorelbine
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine; D000077235:Vinorelbine